-
1دورية أكاديمية
المؤلفون: de Jong, Charlotte G H M, Gabius, Hans-Joachim, Baron, Wia
المصدر: de Jong , C G H M , Gabius , H-J & Baron , W 2019 , ' The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis ' , Cellular and molecular life sciences . https://doi.org/10.1007/s00018-019-03327-7Test
مصطلحات موضوعية: Galectins, Multiple sclerosis, Myelination, Oligodendrocytes, Remyelination, CENTRAL-NERVOUS-SYSTEM, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, GALACTOSIDE-BINDING LECTIN, FYN TYROSINE KINASE, OLIGODENDROCYTE PRECURSOR CELLS, MYELIN SHEATH FORMATION, GROWTH-FACTOR-I, SPINAL-CORD, NEGATIVE REGULATION, REMYELINATION FAILURE
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1007/s00018-019-03327-7Test
https://hdl.handle.net/11370/ad4c425f-d7fe-424d-9ac4-8abe7281af33Test
https://research.rug.nl/en/publications/ad4c425f-d7fe-424d-9ac4-8abe7281af33Test
https://pure.rug.nl/ws/files/99866758/The_emerging_role_of_galectins_in_re_myelination_and_its_potential_for_developing_new_approaches_to_treat_multiple_sclerosis.pdfTest -
2دورية أكاديمية
المؤلفون: de Jong, Charlotte G H M, Stancic, Mirjana, Pinxterhuis, Tineke H, van Horssen, Jack, van Dam, Anne-Marie, Gabius, Hans-Joachim, Baron, Wia
المساهمون: Dutch MS Research Foundation, School of Behavioral and Cognitive Neurosciences
المصدر: Journal of Neuropathology & Experimental Neurology ; volume 77, issue 11, page 1024-1038 ; ISSN 0022-3069 1554-6578
مصطلحات موضوعية: Cellular and Molecular Neuroscience, Neurology (clinical), Neurology, General Medicine, Pathology and Forensic Medicine
الإتاحة: https://doi.org/10.1093/jnen/nly081Test
http://academic.oup.com/jnen/article-pdf/77/11/1024/26000030/nly081.pdfTest -
3دورية أكاديمية
المؤلفون: de Jong, Charlotte G. H. M.1 (AUTHOR), Gabius, Hans-Joachim2 (AUTHOR), Baron, Wia1 (AUTHOR) w.baron@umcg.nl
المصدر: Cellular & Molecular Life Sciences. Apr2020, Vol. 77 Issue 7, p1289-1317. 29p. 1 Color Photograph, 1 Diagram, 3 Charts.
مصطلحات موضوعية: *OLIGODENDROGLIA, *MULTIPLE sclerosis, *NATALIZUMAB, *MYELINATION, *CENTRAL nervous system diseases, *NEUROGLIA